Home NDC 71687-3003 Pamprin Multi-Symptom
Product NDC 71687-3003
11-digit product format 716873003
Labeler code 71687
Product ID 71687-3003_4fe8f1cd-8250-e908-e063-6394a90a1173
Type HUMAN OTC DRUG
Nonproprietary name Acetaminophen, Pamabrom, Pyrilamine maleate
Dosage form TABLET
Route ORAL
Labeler Focus Consumer Healthcare, LLC
Application M013
Marketing category OTC MONOGRAPH DRUG
Marketing start 2016-06-01
Substance PYRILAMINE MALEATE; PAMABROM; ACETAMINOPHEN
Active strength 15; 25; 500 mg/1; mg/1; mg/1
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 21 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Code Status Snapshot Source SHA-256 2025-04-01 02:39 UTC · source 2025-03-31 excluded product product I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 71687-3003-4 I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 71687-3003-1 I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 71687-3003-4 I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 71687-3003-1 I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 71687-3003-4 I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 71687-3003-1 I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 71687-3003-4 I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 71687-3003-1 I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product U Excluded because listing certification expired 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 71687-3003-4 U Excluded because listing certification expired 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 71687-3003-1 U Excluded because listing certification expired 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product U Excluded because listing certification expired ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 71687-3003-4 U Excluded because listing certification expired ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 71687-3003-1 U Excluded because listing certification expired ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product U Excluded because listing certification expired 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 71687-3003-4 U Excluded because listing certification expired 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 71687-3003-1 U Excluded because listing certification expired 0efc9e666f02…f202fb6c5f17…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base Pamprin Multi-Symptom
Brand name suffix Maximum Strength
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength PYRILAMINE MALEATE 15 mg/1 PAMABROM 25 mg/1 ACETAMINOPHEN 500 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 3 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination R35D29L3ZA Internal UNII lookup UA8U0KJM72 Internal UNII lookup 362O9ITL9D Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 1052637 Internal RxNorm lookup 1053852 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 71687-3003-1 Pamprin Multi-SymptomMaximum Strength 20 in 1 BOTTLE, PLASTIC TABLET 20 5 71687-3003-1 Pamprin Multi-SymptomMaximum Strength 1 in 1 CARTON TABLET 1 5 71687-3003-4 Pamprin Multi-SymptomMaximum Strength 1 in 1 CARTON TABLET 1 5 71687-3003-4 Pamprin Multi-SymptomMaximum Strength 40 in 1 BOTTLE, PLASTIC TABLET 40 5
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 71687-3003 PAMPRIN MULTI-SYMPTOM MAXIMUM STRENGTH (ACETAMINOPHEN, PAMABROM, PYRILAMINE MALEATE) TABLET [FOCUS CONSUMER HEALTHCARE, LLC] 4 Current NDC, Legacy NDC, 4 package rows 20250416_60b3286d-5698-df50-e053-2991aa0afbe2.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 14 of 83 · 1,657 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join CHILDRENS PAIN RELIEVER and FEVER REDUCER GRAPE ACETAMINOPHEN DeMoulas Market Basket 0ff5c86e-d84b-42ad-b749-636ab2e3734e 2026-05-09 Warnings Exact identifier application number: M013 Aspirin Regular Strength ASPIRIN Rugby Laboratories 939fce7e-55df-4dc5-916b-a533448e962f 2026-05-08 Warnings Exact identifier application number: M013 Kids Pain and Fever ACETAMINOPHEN Genexa Inc. f7e6e984-f0c3-ed40-e053-6294a90a89f7 2026-05-08 Warnings Exact identifier application number: M013 Genexa Infants Pain and Fever ACETAMINOPHEN Genexa Inc. c59cbf0e-1381-4dd2-e053-2a95a90a853a 2026-05-08 Warnings Exact identifier application number: M013 Genexa Acetaminophen Extra Strength ACETAMINOPHEN Genexa Inc. d6f968ca-719f-5a68-e053-2995a90a4afa 2026-05-08 Warnings Exact identifier application number: M013 Kids Pain and Fever ACETAMINOPHEN Genexa Inc. a7bd0b92-6f85-6175-e053-2995a90ab837 2026-05-08 Warnings Exact identifier application number: M013 Acetaminophen ACETAMINOPHEN Bryant Ranch Prepack 816b65d7-e53f-44c4-a418-074279d4b2af 2026-05-08 Warnings Exact identifier application number: M013 Headache Relief ACETAMINOPHEN, ASPIRIN, CAFFEINE Amerisource Bergen 566dbd02-5e04-4461-8f5f-9fb58a42a375 2026-05-07 Warnings Exact identifier application number: M013 Back and Body Extra Strength ASPIRIN, CAFFEINE DOLGENCORP, LLC d4c0c81b-9176-47d0-a5e4-a584406078d9 2026-05-07 Warnings Exact identifier application number: M013 Extra Strength Acetaminophen ACETAMINOPHEN Pinnacle RX LLC 513cf0e1-6874-9402-e063-6294a90aedc6 2026-05-07 Warnings Exact identifier application number: M013 Infants Pain and Fever Cherry Flavor ACETAMINOPHEN Genexa Inc. 19215ea7-d55f-8d81-e063-6294a90a4924 2026-05-07 Warnings Exact identifier application number: M013 up and up acetaminophen infants ACETAMINOPHEN Target Corporation c1dd8330-fb6b-4d1f-9484-c199dc69214d 2026-05-07 Warnings Exact identifier application number: M013 Extra Strength Aspirin ASPIRIN HHH Pharmaceuticals 90d457bb-79a7-4759-8ee7-6abffbe1e549 2026-05-06 Warnings Exact identifier application number: M013 Aspirin 81mg Enteric Coated ASPIRIN HHH Pharmaceuticals d81aec73-c7c1-4c52-80f6-fb0e32caf7aa 2026-05-06 Warnings Exact identifier application number: M013 Pain Reliever ACETAMINOPHEN HHH Pharmaceuticals 0c66b05d-132d-4c79-abfe-415fd68bbb9c 2026-05-06 Warnings Exact identifier application number: M013 Aspirin ASPIRIN Better Living Brands, LLC 5ebd04d8-52c7-4c72-a4c1-fc7fd488ea24 2026-05-06 Warnings Exact identifier application number: M013 Back and Body Extra Strength ASPIRIN, CAFFEINE Cardinal Health 110, LLC. DBA Leader 519eb216-9fa6-4d60-a2a4-3310bdb5b4ab 2026-05-06 Warnings Exact identifier application number: M013 Aspirin ASPIRIN Geiss, Destin & Dunn Inc. b8f6e486-5332-4c46-ab6c-7de04c91c60b 2026-05-06 Warnings Exact identifier application number: M013 MAX relief junior Grape CHILDRENS ACETAMINOPHEN ATLANTIC BIOLOGICALS CORP. c60494f0-5a50-41da-bcb4-88178ded54b7 2026-05-05 Warnings Exact identifier application number: M013 equate pain relief pm ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE WALMART INC. 85129749-c1a7-4c4a-933f-c3c4768e2cdd 2026-05-05 Warnings Exact identifier application number: M013
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 71687-3003-1 71687300301 1 BOTTLE, PLASTIC in 1 CARTON (71687-3003-1) / 20 TABLET in 1 BOTTLE, PLASTIC 2016-06-01 0000-00-00 No No Current 71687-3003-4 71687300304 1 BOTTLE, PLASTIC in 1 CARTON (71687-3003-4) / 40 TABLET in 1 BOTTLE, PLASTIC 2016-06-01 0000-00-00 No No Current